Parturition in the ewe is preceded by an increase in the synthesis of prostaglandins (PGs) by gestational tissues. To establish the uterine source of these PGs, placental cotyledons, fetal membranes and maternal uterine tissues were collected from ewes (n=6) at spontaneous parturition. Solubilised tissue extracts were prepared and analysed by Western blots using polyclonal antibodies to PG G/H synthase-1 and -2 (PGHS-1 and PGHS-2). PGHS-1 was expressed by all intrauterine tissues at term labour. Densitometric analysis of Western blot autoradiographs showed that the fetal membranes and maternal cervix contained the largest amounts of PGHS-1. PGHS-1 enzyme content of ovine amnion was significantly greater than that of either chorion or allantois (P<0·05). PGHS-1 protein content of myometrial, endometrial and cotyledonary tissue extracts was minimal. Formation of the PGHS-2 isozyme was confined to placental tissue at term labour. PGHS-2 protein levels in sheep placenta were significantly higher than those of PGHS-1 in all intrauterine tissues examined. This result supports the hypothesis that PGHS-2 is a major contributor to PG formation at term labour.
Abstract
Parturition in the ewe is preceded by an increase in the synthesis of prostaglandins (PGs) by gestational tissues. To establish the uterine source of these PGs, placental cotyledons, fetal membranes and maternal uterine tissues were collected from ewes (n=6) at spontaneous parturition. Solubilised tissue extracts were prepared and analysed by Western blots using polyclonal antibodies to PG G/H synthase-1 and -2 (PGHS-1 and PGHS-2). PGHS-1 was expressed by all intrauterine tissues at term labour. Densitometric analysis of Western blot autoradiographs showed that the fetal membranes and maternal cervix contained the largest amounts of PGHS-1. PGHS-1 enzyme content of ovine amnion was significantly greater than that of either chorion or allantois (P<0·05). PGHS-1 protein content of myometrial, endometrial and cotyledonary tissue extracts was minimal. Formation of the PGHS-2 isozyme was confined to placental tissue at term labour. PGHS-2 protein levels in sheep placenta were significantly higher than those of PGHS-1 in all intrauterine tissues examined. This result supports the hypothesis that PGHS-2 is a major contributor to PG formation at term labour.
To elucidate the developmental changes in PGHS-1 and PGHS-2 relative to labour onset, an experimental paradigm of glucocorticoid-induced delivery was used. Previous characterisation and validation of this labour model demonstrated that direct, transabdominal, intrafetal injection of the synthetic glucocorticoid betamethasone (5·7 mg in 1 ml aqueous vehicle) on day 131 of gestation induced labour onset in 56·6 0·8 h (mean ...). As the latent period to induced-labour was known, the time course of enzyme formation could be ascertained. Sheep (n=20) were killed by barbiturate injection at various time intervals post-injection (0, 14, 28, 42 and 56 h) . Tissue extracts collected at post-mortem examination were prepared and analysed by Western blots. PGHS-2 was induced in ovine cotyledon in a time-dependent fashion following glucocorticoid injection (P<0·05). There was a 12-fold increase in abundance between the time of betamethasone administration (0 h) and established labour (56 h). The PGHS-2 isozyme was not detected in any of the other tissues examined. In contrast, formation of the PGHS-1 isozyme did not change in relation to inducedlabour in any of the intrauterine tissues. This finding is consistent with constitutive formation of PGHS-1.
Previous studies have demonstrated a rise in PG production in association with glucocorticoid-induced labour and spontaneous delivery. The results of the present study indicate that this rise in PG production is due to increased formation of the PGHS-2 isozyme in ovine cotyledon.
Introduction
Parturition in the sheep is preceded by activation of the fetal hypothalamic-pituitary-adrenal axis (Liggins et al. 1973) . Cortisol production from the fetal adrenal gland provides the trigger for labour onset by inducing changes in maternal progesterone concentrations, resulting in a concomitant increase in placental oestrogen output (Flint et al. 1976) . The rise in the oestrogen/progesterone ratio enhances the sensitivity of the myometrium to stimulatory agonists such as prostaglandin (PG) F 2 (PGF 2 ), PG E 2 (PGE 2 ) and oxytocin (Liggins et al. 1973) . Furthermore, the change in the steroid milieu increases the secretion rate of PGF 2 from uterine tissues, including the maternal placenta, endometrium and fetal membranes (Challis et al. 1972 , Currie et al. 1973 , Taylor et al. 1982 .
Dexamethasone, a glucocorticoid receptor agonist, has been shown to stimulate PGE 2 formation by human amnion cells in culture (Mitchell et al. 1988 , Potestio et al. 1988 . Similarly, PGF 2 production increases several-fold in maternal placental cotyledons and uterine venous plasma following labour induction in the ewe (Liggins & Grieves 1971) . Evidence suggests that the effects of glucocorticoids on PG production are mediated by an increase in the protein content (Boshier et al. 1991 , Rice et al. 1992 or activity (Rice et al. 1988 (Rice et al. , 1990 of PG G/H synthase (PGHS). The ability of the anti-progesterone and anti-glucocorticoid, RU486, to block the stimulatory effect of dexamethasone on PGE 2 output by human amnion cells suggests that the effect is receptor-mediated (Potestio et al. 1988) .
Two PGHS isozymes have been identified and sequenced. PGHS-1, initially cloned and purified from ram seminal vesicular glands (Merlie et al. 1988) , is a homodimer with a subunit molecular mass of 70 kDa. PGHS-1 protein formation is constitutive and it is thought to play an important role in cellular housekeeping functions (Wang et al. 1993) . PGHS-2 conversely, shares approximately 60% amino acid sequence homology with PGHS-1 (Xie et al. 1991) . Unlike PGHS-1, PGHS-2 content is transiently induced by a variety of agonists, including growth factors, phorbol esters and bacterial exotoxin (Kujubu et al. 1991 , O'Sullivan et al. 1992 , Hamasaki et al. 1993 .
The rise in the PG synthetic capacity of intrauterine tissues brought about by glucocorticoid-induced parturition serves as an important model to determine whether corticosteroids are temporally related to the induction of PGHS. We have previously characterised and validated such an experimental model (McLaren et al. 1996) . Intrafetal injection of the glucocorticoid betamethasone (5·7 mg) induced labour within 57 h in the ewe and resulted in endocrine profiles analogous to those observed at spontaneous-onset delivery. In the present study, we have utilised this model to characterise the localisation and developmental changes in PGHS-1 and PGHS-2 in ovine intrauterine tissues in the period immediately preceding labour onset. The results obtained have been compared with those of intrauterine tissues collected from ewes at spontaneous parturition.
Materials and Methods

Spontaneous labour animals
Six Border-Leicester/Merino cross-bred ewes of known gestational age were allowed to progress to spontaneous parturition. Ewes underwent surgery between 117 and 125 days of gestation to suture electromyographic (EMG) electrodes onto the surface of the myometrium. At day 140 of gestation, the EMG electrodes were connected to a polygraph recorder to monitor alterations in uterine activity. When ewes had been exhibiting signs of increased myometrial contractile activity characteristic of labour (Harding et al. 1982) for a period of 6-8 h, the ewe and fetus were killed by an overdose of barbiturate. Subsequently, a post-mortem examination was performed to collect tissues for Western blot analyses.
Labour induction and experimental protocol
Twenty Border-Leicester/Merino cross-bred ewes were used for labour induction. Labour was induced in ewes by the intrafetal administration of glucocorticoid on day 131 of gestation. Injection procedures were performed with the ewe held in a reclined or sitting attitude to minimise stress. Food was withheld from the ewe 8-12 h before ultrasonic examination to reduce intestinal gas.
The anterior abdominal wall of the sheep was closely shaved with fine animal clippers and sterilised with 70% ethanol. The fetus was then imaged with an ultrasound system (Diagnostic Ultrasound Equipment, model SDL-30; Shimadzu Corporation, Kyoto, Japan). The transducer was placed on the shaved area of skin (or on the bare inguinal region adjacent to the udder) to project an image on the monitor. The fetal heart and chest were visualised to ascertain the spatial orientation of the fetus. The fetal lamb was then injected i.m. in the shoulder or the hindlimb using a sterile 9 cm 20-gauge spinal needle (Terumo Medical Corporation, Tokyo, Japan).
Animals were administered 5·7 mg betamethasone (Celestone Chronodose in 1 ml aqueous vehicle; Schering Plough Pharmaceuticals, Baulkham Hills, NSW, Australia) using ultrasound guidance on day 131 of gestation (time 0). Sterile Indian ink was mixed with the glucocorticoid prior to injection. The position of the injection was then verified at post-mortem examination by the localisation of Indian ink staining. To examine the temporal pattern of PGHS-1 and PGHS-2 protein formation following glucocorticoid injection, ewes were killed at 0, 14, 28, 42 or 56 h postinjection (n=4). At the time of killing, ewes in the 56 h time group had been exhibiting signs of labour consistently over 6-8 h. Labour onset was determined from clinical factors such as swelling of the maternal vulva, and in some cases discharge of amniotic fluid. Animals were killed by the i.v. administration of a lethal dose (20 ml) of 325 mg/ ml sodium pentobarbitone (Lethobarb; Arnolds of Reading Pty, Ltd, Peakhurst, NSW, Australia). A post-mortem examination was conducted and tissues were collected for Western blot analysis.
Tissue collection
Tissues collected at post-mortem examination, including cotyledons, amnion, chorion, allantois, myometrium, endometrium and cervix were excised in the shortest possible time to prevent tissue necrosis and proteolytic degradation. Sampling was restricted to the midline of the ventral uterus, midway between the cervix and the bifurcation of the uterine horns. Endometrial tissue samples were taken from inter-caruncular regions. Tissues were immediately placed in liquid nitrogen before storage at 70 C.
Solubilisation of tissue extracts
Microsomal cell extracts were prepared as previously described (McLaren et al. 1996) . Approximately 1·5 g wet weight of tissue were thawed to 4 C and homogenised. Prior to preparation, tissues were cleaned of connective tissue and washed free of clots in ice-cold Tris-buffered saline (TBS; pH 7·5) containing 20 mM Tris, 0·5 M NaCl, 0·1 M polymethylsulphonyl fluoride and 5 mM EDTA. Cotyledonary tissue samples had tissue of the zona intima dissected free from the capsule and central haemophagous segment prior to homogenisation. Tissue was homogenised for two 20 s bursts using a metal blade homogeniser (Ultra Turrax T25; IKA-Labortechnik, Staufen, Germany). Homogenisation of tissue was performed on ice in TBS (pH 7·5) at 5:1 w/v. The homogenate was then centrifuged at 10 000 g for 10 min at 4 C (Sorvall centrifuge; Newtown, CT, USA). The supernatant was collected and the pellet discarded. The cell extract was then centrifuged at 148 000 g for 60 min at 4 C. The resulting microsomal preparation was solubilised in TBS (pH 7·5) containing 0·1% Tween-20 (TTBS) and stored at 70 C until electrophoretic analysis.
Protein content determination
The protein concentration of solubilised microsomal cell extracts was determined using the method of Bradford (1976) . BSA (CSL Ltd, Parkville, Victoria, Australia) was used to make reference standards ranging in concentration from 0 to 20 µg. Bio-Rad (Hercules, CA, USA) dye reagent concentrate was used for colour development. The depth of colour, measured at an absorbance wavelength of 720 nm (Titretek Multiskan MC, type 340; Eflab Oy, Helsinki, Finland), was analysed after 10 min against a reagent blank prepared from distilled water. The amount of protein was plotted against the corresponding absorbance, resulting in a standard curve used to determine the protein in unknown samples.
Generation of the PGHS-1 antibody
A polyclonal PGHS-1 antiserum was raised in female New Zealand white rabbits (1·5 kg body weight; n=3). PGHS used for injection (from ram seminal vesicle, 99% purity) was purchased from Oxford Biochemicals Company (Oxford, MI, USA). Animals were immunised by multiple-site s.c. injection of PGHS (60 µg in 300 µl saline:Freund's complete adjuvant (1:1 v/v) per rabbit), three times at intervals of 2 weeks. Booster immunisations were administered, thereafter, at intervals of 6 weeks. Six months after the initial immunisation, rabbits were bled and serum was collected. The antiserum was then stored at 20 C until required for use. The cross-reaction of the antibody with the PGHS-2 isozyme was estimated to be <0·1%, as determined from laser densitometry (McLaren et al. 1996) .
Generation of the PGHS-2 antibody
A polyclonal sheep antiserum, specific against the PGHS-2 isozyme, was raised by immunisation with a peptide synthesised by Chiron Mimotopes Pty, Ltd (Clayton, Victoria, Australia). An 18 amino acid PGHS-2 Cterminal peptide (Ac-SRSGLDDINPTVLLKERS-NH 2 ) was synthesised and covalently coupled to diphtheria toxoid via a cysteine residue at the N-terminal end of the peptide sequence (97% purity). The peptide-carrier conjugate was injected into two sheep, at 100 nmol peptide per injection, on day 1 using Freund's complete adjuvant and on day 14 using Freund's incomplete adjuvant. Prior to immunisation with the peptide, the sheep were bled to obtain a pre-immune serum sample. Both sheep were then bled on day 35 (3 weeks after the second injection) to obtain hyperimmune anti-peptide serum samples. Because the antiserum was raised against an 18 amino acid sequence present in the C-terminal portion of the PGHS-2 isozyme (O'Banion et al. 1992) , and the sequence is not present in the PGHS-1 molecule, the antiserum did not cross-react with PGHS-1 isozyme.
SDS-PAGE
Microsomal cell extracts (50-150 µg protein/lane; refer to figure legends), PGHS-1 or PGHS-2 standards and high molecular mass markers were prepared for electrophoretic separation as previously described (McLaren et al. 1996) . Samples were heated to 100 C for 2 min in SDSsample loading buffer (99 mM Tris, 2·0% SDS, 2 mM EDTA, 10% glycerol and 0·05% bromophenol blue, pH 9·2; 30 µl/sample). Following denaturation, 2 µl 2-mercaptoethanol were added to each sample. Samples were then separated on 6-15% polyacrylamide gradient gels using an SE 600 Dual Cooled Vertical Slab Electrophoresis Unit (Hoefer Scientific Instruments, San Francisco, CA, USA). A current of 10 mA and an offset voltage of 340 V was applied to the gel for approximately 16 h for electrophoretic separation of proteins. Proteins were then transferred to nitrocellulose membranes (0·45 µm) using a 2117-250 NovaBlot Electrophoretic Transfer kit (LKB Produkter AB, Bromma, Sweden). A current of 0·8 mA/cm 2 of membrane (100 V offset voltage) was applied for a period of 2 h to achieve complete transfer.
Non-specific binding was blocked by incubating the membrane with TTBS for 30 min. PGHS-1 antibody was used at a final dilution of 1:250 in TTBS diluent. PGHS-2 antibody was used at a final dilution of 1:12 000 in TTBS diluent. Membranes were incubated with the primary antibody for 1 h. To enable detection of the primary PGHS-2 antibody using 125 I-Protein A, membranes incubated with the Chiron PGHS-2 antiserum (raised in sheep) were subsequently incubated with rabbit antisheep immunoglobulins at a final dilution of 1:8000 for 30 min. The coefficient of variation (CV) of replicate samples of the same tissue within a single Western blot analysis using the PGHS-1 antiserum was 11·02%. The CV of replicate samples between analyses was 13·64%. The CV of replicate samples of the same tissue within a single Western blot analysis using the Chiron PGHS-2 antiserum was 10·67%. The CV of replicate samples between analyses was 13·12%.
125 I-Protein A, supplied in 0·05 M sodium phosphate buffer (pH 4·0) containing 35% ethanol (DuPont NEN Products, Boston, MA, USA), was used to detect binding of the primary antibody to the nitrocellulose membrane. Protein A (a component of the cell wall of Staphylococcus aureus) binds to the Fc portion of most immunoglobulin classes; however, it is non-reactive with antibodies derived from the sheep. Binding with rabbit immunoglobulins is strong. Iodinated tracer (approximately 1 10 6 c.p.m. in 30 ml TTBS) was incubated with Amberlite resin IRA-400 (BDH Chemicals, Kilsyth, Victoria, Australia) prior to incubation with the membrane to remove any free (unbound) 125 I. Membranes were incubated with the radiolabel for 2 h. Membranes were then washed in TTBS three times (20 min washes). At the conclusion of the washing step, membranes were monitored with a handheld Mini-monitor (Series 900; Neomedix Systems, Sydney, Australia) to ensure that no radioactivity was present in regions of the filter that carried no protein.
Membranes were exposed to X-ray film (Kodak XAR-5; Eastman Kodak Company, Rochester, NY, USA) for 12-48 h with an intensifying screen. Autoradiographs were analysed by laser densitometry (Molecular Dynamics, Sunnyvale, CA, USA) and image analysis software (Image Quant, Molecular Dynamics). The amount of PGHS-1 or PGHS-2 protein loaded in the standard lanes was plotted against the corresponding density of the signal, resulting in a standard curve used to determine the enzyme content in unknown samples. The relationship between the amount of standard loaded on the gel and the densitometric value obtained was linear for both isoforms. Results for unknown samples are expressed as nanograms PGHS-1 or PGHS-2 per microgram of protein loaded.
Statistical analyses
Statistical analysis of the data was performed using a commercially available statistics package (Statistical Packages for Social Sciences (SPSS-X)) Information Analysis System; SPSS Inc., Chicago, IL, USA). Data were first analysed by univariate homogeneity of variance tests (Bartlett Box F and Cochrane's C test) . If the raw data were inhomogeneous, the tests were repeated using log 10 transformation and square root transformation. The transform most closely attaining homogeneity was then used for all subsequent statistical analyses. Western blot data were analysed by ANOVA, where time and tissue type were the factors. The post-hoc test of least significant difference was used subsequent to the ANOVA to identify significant differences between pairs of mean values. A probability level of 5% (P<0·05) was specified as significant. The data are presented graphically in their untransformed state. Values are expressed as mean ...
Results
Spontaneous parturition
PGHS-1 immunoreactivity
Immunoreactive PGHS-1 in ovine intrauterine tissues at term labour is shown in Fig. 1 . PGHS-1 appeared as a 70 kDa band. In ovine cotyledon, a smaller 66 kDa fragment was also detected. The smaller immunoreactive protein has been reported previously in rats and sheep (Sirois & Richards 1992 , Wimsatt et al. 1993 , McLaren et al. 1996 and is believed to correspond to a proteolytic breakdown product. Alternately, it may represent an N-glycosylation variant of the PGHS-1 enzyme (Otto et al. 1993) . The fetal membranes (amnion, chorion and allantois) and maternal uterine tissues (myometrium, endometrium and cervix) did not demonstrate immunoreactivity at the 66 kDa level. The reason for this occurrence is not known.
PGHS-1 was weakly expressed in ovine placenta at term labour (Fig. 1A) , reaching a mean concentration of 0·22 0·04 ng/µg protein loaded onto the gel (Fig. 2) . The migratory pattern of the cotyledonary tissue extracts on the Western blot was slightly slower than that of the purified PGHS-1 standard. The reason for this occurrence, however, is not known. In contrast to sheep placenta, PGHS-1 was strongly expressed in amnion (Fig. 1B) and cervix ( Fig. 1D) at spontaneous parturition. Densitometric quantitation of the bands demonstrated mean concentrations of 4·22 0·72 and 3·01 0·43 ng/µg protein loaded respectively (Fig. 2) . PGHS-1 concentrations in chorion and allantois were also high; however, final levels achieved were significantly lower than those observed in amnion (1·05 0·36 and 1·59 0·08 ng/µg protein loaded respectively (Fig. 2) . PGHS-1 was weakly expressed in endometrium and myometrium. The mean concentration of PGHS-1 in inter-caruncular endometrial samples at term labour was 0·39 0·14 ng/µg protein loaded. Myometrial samples reached a mean concentration of 0·55 0·06 ng/µg protein loaded (Fig. 2) . Fig. 3A . The PGHS-2 isozyme (estimated to be a 70 kDa fragment) was strongly expressed in ovine placenta at term labour. Formation of PGHS-2 in ovine cotyledon was significantly greater (P<0·001) than that observed for PGHS-1. The mean concentration of PGHS-2 at term labour was 19·18 2·23 ng/µg protein loaded (Fig. 3B) . In contrast, PGHS-2 was not detected in the fetal membranes (amnion, chorion and allantois) and maternal 
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gestational tissues (myometrium, endometrium and cervix). These tissues did not express an immunoreactive band that co-migrates with PGHS-2 standard (data not shown).
Glucocorticoid-induced labour
PGHS-1 and PGHS-2 protein content in ovine cotyledon
The temporal patterns of PGHS-1 and PGHS-2 in ovine cotyledon relative to glucocorticoidinduced labour are shown in Fig. 4A and B respectively. PGHS-1 was constitutively expressed in sheep placenta prior to glucocorticoid injection. Tissue sections collected on day 131 of gestation (0 h; time of injection of betamethasone) demonstrated weak immunoreactive bands on the Western blot autoradiograph. Quantitation of PGHS-1 formation by ovine cotyledon demonstrated a 3·5-fold increase in protein levels between the time of glucocorticoid administration (0 h) and induced-labour (56 h; P<0·05; Fig. 5A ).
In contrast, immunoblots probed with the PGHS-2 antibody demonstrated a large increase in protein content (Fig. 4B ). There was a 12-fold increase in protein levels between the time of glucocorticoid administration and induced-labour (Fig. 5B) . Enzyme induction had occurred as early as 14 h post-injection, with maximal levels observed at labour onset (56 h post-injection). Interestingly, PGHS-2 protein levels were 22-fold higher than those observed for PGHS-1 in ovine cotyledon at the time of intrafetal glucocorticoid administration (0 h). The differential pattern of formation of the isozymes of PGHS in ovine placental tissue substantiates our previous data (McLaren et al. 1996) and working hypothesis that PGHS-2 is the principal enzyme induced in preparation for labour. fetal membranes was markedly different from that detected in cotyledon. PGHS-1 protein levels were high in amnion (Fig. 6A), chorion (Fig. 6B) and allantois (Fig. 6C ) when compared with cotyledonary samples. The pattern of PGHS-1 formation recognised by the antibody was similar in all the fetal membranes, with a transient fall in signal intensity observed 28 h after injection with glucocorticoid. The reason for this fall in protein levels is not known. Quantitative comparisons of PGHS-1 formation by ovine amnion with the other fetal membranes demonstrated higher immunoreactivity at all the time points examined. At the time of injection (0 h), PGHS-1 in amnion was 24·5 times higher than that observed in chorion and 6·5 times higher than that observed in allantois (Fig. 7A-C) . PGHS-1 in chorion and allantois was significantly increased 14 h after intrafetal injection with glucocorticoid (P<0·05); however, enzyme formation was not induced in response to labour onset.
PGHS-1 and PGHS-2 protein content in ovine fetal membranes The regulation of PGHS enzymes in the
When duplicate blots were probed for PGHS-2, no immunoreactivity was detected (data not shown). PGHS-2 was not present in the fetal membranes at the time of injection of betamethasone (0 h). Moreover, PGHS-2 enzyme formation was not induced in response to induced-labour.
PGHS-1 and PGHS-2 protein content in maternal intrauterine tissues
Enzyme production in the myometrium, endometrium and cervix was markedly different from that observed in the fetal membranes. PGHS-1 immunoreactivity was minimal and did not change in response to induced-labour (data not shown). There was no consistent pattern of PGHS-1 protein levels across all the time points examined. Densitometric analysis of the Western blot autoradiographs revealed that mean PGHS-1 protein levels in myometrial, endometrial and cervical tissue extracts were significantly lower (P<0·05) than those in the fetal membranes (data not shown). As was demonstrated with the fetal membranes, PGHS-2 protein was not found in maternal uterine tissues. Moreover, enzyme production was not induced by the mechanisms of labour.
Discussion
Normal parturition in the sheep is associated with a marked increase in concentrations of PGF 2 in uteroovarian vein plasma (Mitchell et al. 1979 ) and uterine tissues (Risbridger et al. 1985) . The concentration of PGE 2 in fetal plasma increases before delivery (Challis et al. 1976) . Similarly, the concentration of PGE 2 and PGF 2 in amniotic fluid is elevated in late pregnancy (Mitchell et al. 1977) . Enhanced PG production by intrauterine tissues is a prerequisite for the increased myometrial contractile activity observed at term delivery.
Previously, it was thought that the release of arachidonic acid (AA) (the substrate for PG synthesis) from intracellular stores was the rate-limiting step in the formation of PGs (Flower 1980) . Evidence now suggests that enhanced PGHS synthesis and activity rather than phospholipase activity is rate limiting for prostanoid formation. In sheep, the capacity of dispersed trophoblast cells to synthesise prostanoids is low up to 100-110 days of gestation. During this period, prostanoid synthesis cannot be stimulated by exogenous AA (40 µM) (Risbridger et al. 1985) . This suggests that the activity and/or tissue content of PGHS is low. From 110 days of gestation, PG synthesis increases until term. The rise in PG formation is consistent with an increase in the rate of synthesis of PGHS and/or an increase in the half-life of the enzyme.
The aim of the present study was to examine the temporal pattern of PGHS-1 and PGHS-2 enzyme content in ovine intrauterine tissues using a glucocorticoidinduced labour model and to compare the results with those observed at term delivery. We have previously characterised and validated such a model (McLaren et al. 1996) . The period from the point of intrafetal injection of betamethasone (5·7 mg) to killing following labour onset was 56·6 0·8 h (mean ...). Major endocrine changes recognised in the ewe and fetus before parturition at term were shown to occur before induced premature delivery. Maternal progesterone concentrations decreased significantly (P<0·05). This alteration in steroid biosynthesis is consistent with the induction of 17 -hydroxylase and C 17-20 lyase activities, precipitating the formation of androgens from progesterone or pregnenolone (Flint et al. 1976) . In addition, PG concentrations in fetal, maternal and utero-ovarian vein plasma were elevated.
In sheep, cotyledonary PGHS activity and immunoreactive content rises in the last third of gestation, with a rapid increase associated with labour onset (Mitchell et al. 1979) . Fowden et al. (1987) demonstrated enhanced placental PGE 2 secretion into the maternal and fetal circulations in late gestation. Evans et al. (1981) showed that following adrenocorticotrophic hormone-induced labour, PGF and 6-keto PGF 1 levels were significantly increased in cotyledons and chorioallantois. Rice et al. (1988) demonstrated that the capacity of microsomes prepared from ovine cotyledons to synthesise PGE 2 and PGF 2 from radiolabelled AA increased 25-fold between 20 and 140 days of gestation. Our results support the hypothesis that PGHS-2 is the enzyme mostly responsible for increased PG formation by ovine placenta both at term delivery and induced-labour onset. The transient increase in PGHS-2 following glucocorticoid administration and subsequent labour onset suggests that this isozyme is regulated by the mechanisms controlling parturition in the ewe.
PGHS-2 in sheep placenta, as detected by Western blot analysis, demonstrated a 12-fold increase between glucocorticoid injection and ensuing labour onset (see Fig. 5B ).
A 3-fold increase in protein levels was detected as early as 14 h post-injection. Furthermore, PGHS-2 protein was present in placental extracts on day 131 of gestation (0 h). The presence of the PGHS-2 isozyme prior to day 131 of gestation parallels that of fetal adrenal gland activation. Endogenous cortisol concentrations begin to rise approximately 25 days before delivery (Magyar et al. 1980) . Similarly, PGHS activity begins to increase at 
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110-125 days of gestation in the ewe (Rice et al. 1988) , with a rapid increase in the last 2 weeks of pregnancy.
The temporal pattern of PGHS-2 induction demonstrated by this study is consistent with the endocrine data measured previously to validate the experimental model of intrafetal glucocorticoid administration (McLaren et al. 1996) . Glucocorticoid-induced labour was shown to elicit a significant increase (P<0·05) in arterial plasma concentrations of PGE 2 , PGF 2 and PGFM (the inactive metabolite of PGF 2 ) in the circulation of fetal lambs. In addition, a rise in the concentrations of PGF 2 and PGFM in maternal arterial and uterine venous plasma was observed in response to induced delivery. It was concluded that the increase in prostanoid formation was mediated by the induction of placental PGHS-2 enzyme content. The results from the present study strongly support this hypothesis. Since PGHS is characterised by a short biological half-life (<10 min), the increase in PGHS-2 protein levels shown by the present investigation is consistent with a sustained rise in the rate of synthesis of the enzyme.
In contrast to the PGHS-2 isozyme, PGHS-1 protein levels in ovine cotyledon were low at the time of spontaneous parturition. Furthermore, PGHS-1 protein content increased only slightly following betamethasone administration. This small increase, however, may have been due to partial cross-reaction of the PGHS-1 antibody with the PGHS-2 isozyme. Previous investigations have demonstrated no change in the level of PGHS-1 mRNA (Rice et al. 1995 , Gibb et al. 1996 or protein content (Wimsatt et al. 1993) in association with labour onset in the sheep.
The ovine fetal membranes represent a major source of PG output in late gestation. Olson et al. (1986) measured concentrations of PGE 2 , PGF 2 , PGFM, 6-keto PGF 1 and 6-keto PGE 1 on day 131 of pregnancy. PGE 2 concentrations were high in chorioallantois and amnion tissue extracts. Moreover, Evans et al. (1982) measured intrauterine tissue concentrations of PGE 2 , PGF 2 and 6-keto PGF 1 at different stages of pregnancy in sheep. The concentrations of these PGs in chorioallantois and amnion were significantly higher on days 130 and 145 than on days 50 or 100 of pregnancy.
The results of the present study suggest that PGHS-1 is the enzyme responsible for prostanoid production by ovine fetal membranes. PGHS-1 protein content was high in amnion, chorion and allantois when compared with cotyledonary tissue at term delivery and induced-labour onset. Conversely, the PGHS-2 isozyme was not synthesised in the fetal membranes and was not induced by glucocorticoid administration and subsequent labour onset. Protein levels of PGHS-1 in amnion were generally 2-3 times higher than those expressed by the other fetal membranes. This finding is consistent with the high output of PGs by dispersed amnion cells in vitro (Evans et al. 1982) . This result also supports the findings of Langlois et al. (1993) , who demonstrated that the conversion of AA into PGs by amnion was significantly greater than by chorion between days 78 and 140 of gestation.
In contrast to the fetal membranes, PGHS-1 protein content in myometrial, endometrial and cervical tissue extracts was minimal at term delivery and in the time preceding induced-labour. Protein levels were not consistent across the time points examined and did not increase with labour onset. Furthermore, PGHS-2 was not detected in maternal gestational tissues and did not increase in response to betamethasone-induced labour. These results are in direct contrast to the findings of Zhang et al. (1996) , who demonstrated elevated levels of PGHS-2 in myometrium and endometrium during glucocorticoidinduced premature labour. The reason for this discrepancy in results is not known and can only be resolved through further experimentation.
In conclusion, this study has delineated the localisation and pattern of PGHS-1 and PGHS-2 enzyme content in ovine intrauterine tissues in relation to the initiation of parturition in the ewe. Increased PGHS-2 protein content in sheep placental tissue appears to be the main factor responsible for the pre-partum increase in prostanoid formation observed at term delivery. PGHS-1 protein in the fetal membranes does not change in response to labour while PGHS-1 protein content in maternal gestational tissues is minimal. The exact role of PG production by these tissues is yet to be elucidated.
